Fidelity D&D Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Buy
425
+115
+37% +$118K 0.17% 57
2026
Q1
$285K Buy
310
+45
+17% +$45.6K 0.11% 78
2025
Q4
$285K Sell
265
-16
-6% -$15.3K 0.12% 75
2025
Q3
$214K Sell
281
-40
-12% -$29.8K 0.12% 96
2025
Q2
$250K Hold
321
0.15% 86
2025
Q1
$265K Hold
321
0.17% 82
2024
Q4
$248K Sell
321
-4
-1% -$3.31K 0.16% 93
2024
Q3
$288K Sell
325
-20
-6% -$18K 0.19% 77
2024
Q2
$312K Hold
345
0.24% 69
2024
Q1
$268K Sell
345
-50
-13% -$35.6K 0.2% 76
2023
Q4
$230K Buy
+395
New +$231K 0.18% 86
2023
Q1
$268K Buy
+345
New +$116K 0.2% 76

Other funds holding LLY

Fidelity D&D Bancorp's LLY Position: Q2 2026 in Review

Fidelity D&D Bancorp increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $118K and bringing the position to 425 shares worth $510K. The position accounts for 0.17% of the portfolio, ranked #57.

Fidelity D&D Bancorp first reported a position in LLY in Q1 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fidelity D&D Bancorp held 425 shares of Eli Lilly worth $510K as of Q2 2026.
  • Fidelity D&D Bancorp bought 115 Eli Lilly shares in Q2 2026, an estimated $118K.
  • Eli Lilly made up 0.17% of Fidelity D&D Bancorp's portfolio in Q2 2026, its #57 holding.
  • Fidelity D&D Bancorp first reported a position in Eli Lilly in Q1 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fidelity D&D Bancorp's 13F filing for Q2 2026, filed 6 Aug 2026.